Success Metrics

Clinical Success Rate
70.0%

Based on 7 completed trials

Completion Rate
70%(7/10)
Active Trials
0(0%)
Results Posted
43%(3 trials)
Terminated
3(20%)

Phase Distribution

Ph not_applicable
1
7%
Ph phase_2
2
13%
Ph phase_3
2
13%
Ph phase_4
6
40%
Ph phase_1
1
7%
Ph early_phase_1
1
7%

Phase Distribution

2

Early Stage

2

Mid Stage

8

Late Stage

Phase Distribution13 total trials
Early Phase 1First-in-human
1(7.7%)
Phase 1Safety & dosage
1(7.7%)
Phase 2Efficacy & side effects
2(15.4%)
Phase 3Large-scale testing
2(15.4%)
Phase 4Post-market surveillance
6(46.2%)
N/ANon-phased studies
1(7.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

53.8%

7 of 13 finished

Non-Completion Rate

46.2%

6 ended early

Currently Active

0

trials recruiting

Total Trials

15

all time

Status Distribution
Active(1)
Completed(7)
Terminated(6)
Other(1)

Detailed Status

Completed7
Terminated3
Withdrawn3
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
0
Success Rate
70.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (7.7%)
Phase 11 (7.7%)
Phase 22 (15.4%)
Phase 32 (15.4%)
Phase 46 (46.2%)
N/A1 (7.7%)

Trials by Status

completed747%
not_yet_recruiting17%
terminated320%
withdrawn320%
unknown17%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT07450547Phase 2

Phase 2 Study to Assess the Safety and Efficacy of ANG003

Not Yet Recruiting
NCT01154608Not Applicable

Effect of Enzyme Therapy on Protein Metabolism in Chronic Pancreatitis

Completed
NCT05266963Early Phase 1

Pancreatic Enzyme Replacement and Glucose Regulation in Type 1 Diabetes

Completed
NCT05069597Phase 4

Study to Evaluate Symptoms of Exocrine Pancreatic Insufficiency in Adult Participants With Cystic Fibrosis or Chronic Pancreatitis Treated With Creon

Completed
NCT04949828

Effect of CREON on Exocrine Pancreatic Insufficiency (EPI) Symptoms

Completed
NCT02733848Phase 1

CREON for the Treatment of Post-RYGB Hypoglycemia

Terminated
NCT01228643Phase 3

Effectiveness of Pancreatic Enzymes in Patients Pancreatic Insufficient: Comparison of Two Drugs

Withdrawn
NCT04315311Phase 4

Study Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Pancreatic Cancer

Withdrawn
NCT01652157

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Terminated
NCT01865695Phase 4

Creon Use in Coeliac Patients With Low Faecal Pancreatic Elastase

Terminated
NCT02137382Phase 3

A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect of Creon N and Creon® on Fat Digestion in Subjects ≥ 12 Years of Age With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Completed
NCT02009410Phase 4

A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in Subjects With Diabetes Mellitus Type 2

Withdrawn
NCT00535756Phase 4

Creon After Pancreatic Surgery

Completed
NCT01012908Phase 2

Clinical Non-Inferiority of Pancreatic Enzymes (Norzyme ® - Bergamo) Compared To Creon ® (Solvay Pharmaceutical) in Patients With Exocrine Pancreatic Insufficiency

Unknown
NCT00957151Phase 4

Evaluation of the Digestive and Metabolic Utilisation of Dietary Protein in Patients With Chronic Pancreatitis

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15